CD36 and hyperlipidemia: The contribution of platelet CD36 to hyperlipidemia-related thrombosis has previously been suggested, because the genetic deletion of CD36 in ApoE-deficient mice reduced the platelet hyperreactivity that promoted thrombosis [233].